Financhill
Back

Anheuser-Busch InBev SA/NV Vs. Novo Nordisk AS Industry Stock Comparison

Sell
28

BUD
Anheuser-Busch InBev SA/NV

Last Price:
$50.24
Seasonality Move:
0.1%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
28
Anheuser-Busch InBev SA/NV (BUD) is a Sell

Is Anheuser-Busch InBev SA/NV a Buy, Sell or Hold?

  • The current Anheuser-Busch InBev SA/NV [BUD] share price is $50.21. The Score for BUD is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • BUD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BUD Stock Price Chart

What is Anheuser-Busch InBev SA/NV's stock price today?

  • The Anheuser-Busch InBev SA/NV share price today is $50.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BUD is experiencing slight buying pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

BUD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.8 Sell
Relative Strength Index (14 RSI): 22.01 Sell
Chaikin Money Flow: 870837 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.8 - 55.2) Sell
Bollinger Bands (100): (55.58 - 64.78) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

BUD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.75 Sell
20-day SMA: 52.94 Sell
50-day SMA: 57.53 Sell
200-day SMA: 60.6 Sell
8-day EMA: 51.41 Sell
20-day EMA: 53.02 Sell
50-day EMA: 56.19 Sell
200-day EMA: 59.76 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Anheuser-Busch InBev SA/NV Earnings Growth & BUD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and an increase next year of $0.30 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

Anheuser-Busch InBev SA/NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):